|Last Price||Today's Change||52-Week Range||Trading Volume|
|5.49||-0.01 (-0.18%)||1.26 - 6.81||2.9 million (Below Avg)|
Market data as of 4:00PM 11/25/15. Quotes are delayed by at least 15 min.
Exelixis Announces Presentation of Positive Overall Survival Results for COTELLIC™ in Combination with Vemurafenib in Advanced BRAF V600 Mutation-Positive Melanoma at Society for Melanoma Research 2015 International Congress
11/21/2015 6:40 PM ET